The E-AHPBA–ESSO–ESSR Innsbruck consensus guidelines for preoperative liver function assessment before hepatectomy are being discussed in a webinar.

Humedics GmbH has announced that they will be hosting a webinar on the 22nd November, 2023 at 4:30 to 6:00 p.m. (CET) to highlight the key aspects of the European guidelines for the preoperative measurement of liver function which were published in June of this year. The webinar will also discuss applications of the LiMAx test in hepatology.

Dr. Ralf Kohnen, Humedics GmbH, Bundesallee 23, 10717 Berlin said: “This represents an important milestone for the use of the LiMAx test and underlines its importance for the safety of patients and surgeons. We want to focus on the resulting significance for the use of the LiMAx test in daily practice.”

The LiMAx (Liver Maximum Capacity) test is a diagnostic breath test for the quantitative determination of the maximum enzymatic liver function in adults. The test is based on the metabolization of a non-radioactive and isotope labeled drug, 13C-Methacetin by the cytochrome-P450 (CYP1A2) enzyme. Due to this metabolization the 13CO2 levels in the exhaled air increases. The increase is a direct measure of liver function capacity at the cellular level, called LiMAx.

The Chairman of the webinar will be Martin Stockmann and Johan Lock will be speaking about the key points of the E-AHPBA-ESSO-ESSR guidelines. Martin Stockmann will discuss the LiMAx test in the E-AHPBA-ESSO-ESSR guidelines and recommendations for day-to-day practice. Guido Gerken will be discussing the use of the LiMAx test in hepatology: study data, personal experience and billing tips.

Those interested in attending the webinar can do so using the link: Join LiMAx Webinar (EU Consensus Guideline).

Humedics GmbH has announced that it will be hosting a webinar on the 22nd November, 2023 to discuss the European guidelines for the preoperative measurement of liver function published in June this year. The webinar will also discuss applications of the LiMAx test in hepatology.

Dr. Ralf Kohnen, Humedics GmbH said: “This represents an important milestone for the use of the LiMAx test and underlines its importance for the safety of patients and surgeons. We want to focus on the resulting significance for the use of the LiMAx test in daily practice.”

The LiMAx (Liver Maximum Capacity) test is a diagnostic breath test for the quantitative determination of the maximum enzymatic liver function in adults. The test is based on the metabolization of a non-radioactive and isotope labeled drug, 13C-Methacetin by the cytochrome-P450 (CYP1A2) enzyme. Due to this metabolization the 13CO2 levels in the exhaled air increases. The increase is a direct measure of liver function capacity at the cellular level, called LiMAx.

Martin Stockmann, Chairman of the webinar, will discuss the LiMAx test in the E-AHPBA-ESSO-ESSR guidelines and recommendations for day-to-day practice. Johan Lock will present the key points of the E-AHPBA-ESSO-ESSR guidelines, while Guido Gerken will focus on the use of the LiMAx test in hepatology: study data, personal experience and billing tips.

Those interested in attending the webinar can do so by using the link: Join LiMAx Webinar (EU Consensus Guideline).

Humedics GmbH is hosting a webinar on the 22nd November, 2023 to discuss the European guidelines for the preoperative measurement of liver function. The webinar will be chaired by Martin Stockmann, with Johan Lock presenting the key points of the E-AHPBA-ESSO-ESSR guidelines and Guido Gerken discussing the use of the LiMAx test in hepatology.

Dr. Ralf Kohnen, from Humedics GmbH, said: “This represents an important milestone for the use of the LiMAx test and underlines its importance for the safety of patients and surgeons. We want to focus on the resulting significance for the use of the LiMAx test in daily practice.”

The LiMAx (Liver Maximum Capacity) test is a breath test for the quantitative determination of the maximum enzymatic liver function in adults. The test is based on the metabolization of a non-radioactive and isotope labeled drug, 13C-Methacetin by

Derick is an experienced reporter having held multiple senior roles for large publishers across Europe. Specialist subjects include small business and financial emerging markets.

Leave a Reply

Your email address will not be published. Required fields are marked *